| Filed On | Filing |
|---|---|
| 05 Mar 2026 |
Form 3: Johnson-Greene Treerita Essalima, Chief Financial Officer
Holds 500,000 shares of Common Stock |
| 09 Jun 2025 |
Form 3: Chandrasekhar Satishchandran, Director
No securities owned |
| 09 Jun 2025 |
Form 3: Coleman Blaise, Director
No securities owned |
| 15 Nov 2024 |
Form 3: Ramachandran Ramesh, Chief Accounting Officer
Holds 1,800 shares of Common Stock |
| 20 Mar 2024 |
Form 3: Qamar Huma, Chief Medical Officer
Holds 1,643 shares of Common Stock |
| 20 Mar 2024 |
Form 3: Breininger Michael, See Remarks
No securities owned |
| 10 Mar 2023 |
Form 3: Vu Quan Anh, CFO/CBO
Holds 165,934 shares of Common Stock |
| 05 Jan 2023 |
Form 3: Upadhyay Arun, Chief Scientific Officer
Holds 84,159 shares of Common Stock |
| 23 Mar 2022 |
Form 3: Whittington Marna C, Director
Holds 1,000 shares of Common Stock |
| 22 Mar 2022 |
Form 3: Crespo Jessica, CAO/SVP, Finance
Holds 17,500 shares of Common Stock |
| 08 Apr 2020 |
Form 3: Castillo Kirsten, Director
No securities owned |
| 08 Apr 2020 |
Form 3: Fernandes Prabhavathi, Director
No securities owned |
| 20 Dec 2019 |
Form 3: Potti Manish, Director
Holds 123,429 shares of Common Stock |
| 16 Dec 2019 |
Form 3: Taspolatoglu Suha, Director
Holds 742,905 shares of Common Stock |
| 16 Dec 2019 |
Form 3: Kompella Uday, Director
Holds 950,674 shares of Common Stock |
| 16 Dec 2019 |
Form 3: Kumar Ramesh, Director
No securities owned |
| 16 Dec 2019 |
Form 3: Leo Frank, Director
Holds 103,122 shares of Common Stock |
| 16 Dec 2019 | Form 3: Beck Kelly, Vice President |
| 16 Dec 2019 | Form 3: Tammara Vijay, Vice President |
| 16 Dec 2019 | Form 3: Arumugham Rasappa, Chief Scientific Officer |
Loading...